Washington University in St. Louis COVID-19 nasal vaccine technology licensed to Ocugen
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
On Oct. 4, 2022, the United States Department of Agriculture’s (USDA) Agricultural Research Service (ARS), Southeast Poultry Research…
On Oct. 3, 2022, the Nobel Prize in Physiology or Medicine was awarded to Svante Paabo “for his…
On Sept. 29, 2022, Moderna announced that the European Medicines Agency (EMA) had accepted a variation for the…
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
On Sept. 28, 2022, Pfizer and BioNTech announced they had completed a submission to the European Medicines Agency…
On Sept. 28, 2022, the U.S Department of Agriculture’s Animal Plant Health Inspection Service (USDA APHIS) confirmed two…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
On Sept. 27, 2022, Novavax announced that an initial one million doses of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine were…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced it had launched a program to better…
On Supt. 22, 2022, Pfizer announced an agreement to supply up to six million treatment courses of its…
On Sept. 21, 2022, during United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanthropies,…
On Sept. 20, 2022, health authorities in Uganda declared an outbreak of Ebola after a case of the…
On Sept. 20, 2022, the University of California, Davis announced that the amphibian decline in Latin America in…
On Sept. 17, 2022, the Democratic Republic of the Congo declared the end of an Ebola outbreak that…
On Sept. 16, 2022, Novavax announced that the Israel Ministry of Health has granted an import and use…
On Sept. 16, 2022, Novavax announced that the Taiwan Food and Drug Administration had granted expanded emergency use…
On Sept. 15, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Sept. 15, 2022, Gilead Sciences announced updates to the World Health Organization’s (WHO) Therapeutics and COVID-19: living…
On Sept. 15, 2022, the National Institutes of Health (NIH) announced that a research team funded by the…
On Sept. 14, 2022, The U.S. Biotech Initiative was announced detailing new investments and resources to advance the…
On Sept. 13, 2022, the National Institutes of Health announced it will invest $130 million over four years,…
On Sept. 13, 2022, Novavax and Serum Institute of India, the world’s largest vaccine manufacturer by volume, announced…
On Sept. 8, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced that Stuart and Molly Sloan had pledged…
On Sept. 8, 2022, a clinical trial evaluating alternative strategies for administering the JYNNEOS mpox vaccine to increase…
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
On Sept. 7, 2022, the U.S. Food and Drug Administration (FDA) announced it had approved Revance Therapeutics’ DAXXIFY…
On Sept. 7, 2022, Quest Diagnostics announced that it had received emergency use authorization (EUA) from the U.S….
On Sept. 6, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service had reviewed…
On Sept. 2, 2022, Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, had expanded its temporary…